BIOVENTUS INC. - CLASS A COMMON STOCK
11,75
04-октября-24 15:59:57
15 мин. задержка
Акции
+0,08
+0,69%
Сегодняшний диапазон
11,57 - 11,92
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Bioventus to Report Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022
26 июл 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Bioventus Completes CartiHeal Acquisition
12 июл 2022 08:30:00 Источник Nasdaq GlobeNewswire
-
Bioventus Amends CartiHeal Acquisition Structure
21 июн 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance
10 май 2022 07:00:04 Источник Nasdaq GlobeNewswire
-
03 май 2022 17:47:17 Источник Nasdaq GlobeNewswire
-
02 май 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA
26 апр 2022 09:05:09 Источник Nasdaq GlobeNewswire
-
Bioventus Announces $415 Million Offering of Senior Notes
26 апр 2022 08:38:49 Источник Nasdaq GlobeNewswire
-
Bioventus to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022
25 апр 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Bioventus TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives
08 апр 2022 09:15:08 Источник Nasdaq GlobeNewswire
-
Bioventus Announces Inducement Equity to SVP Chief Financial Officer Mark Singleton
05 апр 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Bioventus Exercises Call Option to Acquire CartiHeal
04 апр 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Bioventus to Present at the Canaccord Genuity Musculoskeletal Conference
16 мар 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
10 мар 2022 07:00:03 Источник Nasdaq GlobeNewswire
-
Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device
01 мар 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Bioventus Appoints Mark Singleton as Chief Financial Officer
28 фев 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Bioventus to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 10, 2022
22 фев 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Bioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue
11 янв 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference
28 дек 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
Bioventus Appoints Michelle McMurry-Heath to Board of Directors
21 дек 2021 09:25:00 Источник Nasdaq GlobeNewswire